Radiation-Induced Lymphopenia Prognosis and Risk Factors in Postmastectomy Radiotherapy Patients

Wenjie Ni, Xiunan Wang, Qin Wang, Yongqing Ge, Xiaofeng Mu Department of Radiation Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Xiaofeng Mu, Email muxiaof@sina.cnObjective: To investigate the effects of radiation-induced lymphope...

Full description

Saved in:
Bibliographic Details
Main Authors: Ni W, Wang X, Wang Q, Ge Y, Mu X
Format: Article
Language:English
Published: Dove Medical Press 2025-05-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/radiation-induced-lymphopenia-prognosis-and-risk-factors-in-postmastec-peer-reviewed-fulltext-article-CMAR
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849417979075231744
author Ni W
Wang X
Wang Q
Ge Y
Mu X
author_facet Ni W
Wang X
Wang Q
Ge Y
Mu X
author_sort Ni W
collection DOAJ
description Wenjie Ni, Xiunan Wang, Qin Wang, Yongqing Ge, Xiaofeng Mu Department of Radiation Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Xiaofeng Mu, Email muxiaof@sina.cnObjective: To investigate the effects of radiation-induced lymphopenia (RIL) on survival in postmastectomy radiotherapy (RT) patients and identify relevant RIL predictive factors.Methods: Patients with breast cancer who received postmastectomy radiotherapy at the study hospital were enrolled over June 2016 to December 2022. The peripheral blood counts were obtained before and during treatment and at the first posttreatment follow-up. Lymphopenia was graded according to the degree of lymphocyte reduction. The Kaplan–Meier method was used to compare disease-free survival (DFS) and overall survival (OS) between grade 0– 2 (G0-2) and grade 3 (G3) lymphopenia, and the Log rank test was used to compare between-group differences. DFS prognostic factors were determined through Cox regression analysis, and G3 lymphopenia predictive factors were assessed through logistic regression analysis.Results: 156 patients with a median RT duration of 5.0 weeks were enrolled. During treatment, 29 (18.6%), 36 (23.1%), 67 (42.9%), and 24 (15.4%) patients had G0, G1, G2, and G3 lymphopenia, respectively. Over RT duration, the absolute lymphocyte counts continued to decrease until they reached the nadir at week 5. The median follow-up duration was 45.5 months. The 1, 3-, and 5-year DFS rates were 97.0%, 90.3%, and 87.4% in the G0-2 group, respectively; they were higher than those in the G3 group (83.3%, 69.2%, and 39.5%, respectively; p < 0.001). Cox univariate and multivariate analyses revealed that pathological stage and lymphopenia degree were independent prognostic factors for DFS (both p < 0.001). Logistic regression analysis revealed that low body mass index (BMI), integrated RT, and high heart (Dmean ≥ 6 Gy) and sternum (Dmean ≥ 20Gy) exposure dose were associated with G3 lymphopenia (all p < 0.05).Conclusion: G3 RIL led to poor DFS in postmastectomy radiotherapy patients. BMI, RT modality, and heart and sternum exposure dose were noted to be independent RIL risk factors.Keywords: breast neoplasm, postoperative radiotherapy, lymphopenia, prognosis
format Article
id doaj-art-030ff730baba4b4ca35dc00f2d22d122
institution Kabale University
issn 1179-1322
language English
publishDate 2025-05-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj-art-030ff730baba4b4ca35dc00f2d22d1222025-08-20T03:32:35ZengDove Medical PressCancer Management and Research1179-13222025-05-01Volume 17Issue 110471058103381Radiation-Induced Lymphopenia Prognosis and Risk Factors in Postmastectomy Radiotherapy PatientsNi W0Wang XWang QGe Y1Mu XDepartment of Radiation Oncologyradiation OncologyWenjie Ni, Xiunan Wang, Qin Wang, Yongqing Ge, Xiaofeng Mu Department of Radiation Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Xiaofeng Mu, Email muxiaof@sina.cnObjective: To investigate the effects of radiation-induced lymphopenia (RIL) on survival in postmastectomy radiotherapy (RT) patients and identify relevant RIL predictive factors.Methods: Patients with breast cancer who received postmastectomy radiotherapy at the study hospital were enrolled over June 2016 to December 2022. The peripheral blood counts were obtained before and during treatment and at the first posttreatment follow-up. Lymphopenia was graded according to the degree of lymphocyte reduction. The Kaplan–Meier method was used to compare disease-free survival (DFS) and overall survival (OS) between grade 0– 2 (G0-2) and grade 3 (G3) lymphopenia, and the Log rank test was used to compare between-group differences. DFS prognostic factors were determined through Cox regression analysis, and G3 lymphopenia predictive factors were assessed through logistic regression analysis.Results: 156 patients with a median RT duration of 5.0 weeks were enrolled. During treatment, 29 (18.6%), 36 (23.1%), 67 (42.9%), and 24 (15.4%) patients had G0, G1, G2, and G3 lymphopenia, respectively. Over RT duration, the absolute lymphocyte counts continued to decrease until they reached the nadir at week 5. The median follow-up duration was 45.5 months. The 1, 3-, and 5-year DFS rates were 97.0%, 90.3%, and 87.4% in the G0-2 group, respectively; they were higher than those in the G3 group (83.3%, 69.2%, and 39.5%, respectively; p < 0.001). Cox univariate and multivariate analyses revealed that pathological stage and lymphopenia degree were independent prognostic factors for DFS (both p < 0.001). Logistic regression analysis revealed that low body mass index (BMI), integrated RT, and high heart (Dmean ≥ 6 Gy) and sternum (Dmean ≥ 20Gy) exposure dose were associated with G3 lymphopenia (all p < 0.05).Conclusion: G3 RIL led to poor DFS in postmastectomy radiotherapy patients. BMI, RT modality, and heart and sternum exposure dose were noted to be independent RIL risk factors.Keywords: breast neoplasm, postoperative radiotherapy, lymphopenia, prognosishttps://www.dovepress.com/radiation-induced-lymphopenia-prognosis-and-risk-factors-in-postmastec-peer-reviewed-fulltext-article-CMARBreast neoplasmPostoperative radiotherapyLymphopeniaPrognosis
spellingShingle Ni W
Wang X
Wang Q
Ge Y
Mu X
Radiation-Induced Lymphopenia Prognosis and Risk Factors in Postmastectomy Radiotherapy Patients
Cancer Management and Research
Breast neoplasm
Postoperative radiotherapy
Lymphopenia
Prognosis
title Radiation-Induced Lymphopenia Prognosis and Risk Factors in Postmastectomy Radiotherapy Patients
title_full Radiation-Induced Lymphopenia Prognosis and Risk Factors in Postmastectomy Radiotherapy Patients
title_fullStr Radiation-Induced Lymphopenia Prognosis and Risk Factors in Postmastectomy Radiotherapy Patients
title_full_unstemmed Radiation-Induced Lymphopenia Prognosis and Risk Factors in Postmastectomy Radiotherapy Patients
title_short Radiation-Induced Lymphopenia Prognosis and Risk Factors in Postmastectomy Radiotherapy Patients
title_sort radiation induced lymphopenia prognosis and risk factors in postmastectomy radiotherapy patients
topic Breast neoplasm
Postoperative radiotherapy
Lymphopenia
Prognosis
url https://www.dovepress.com/radiation-induced-lymphopenia-prognosis-and-risk-factors-in-postmastec-peer-reviewed-fulltext-article-CMAR
work_keys_str_mv AT niw radiationinducedlymphopeniaprognosisandriskfactorsinpostmastectomyradiotherapypatients
AT wangx radiationinducedlymphopeniaprognosisandriskfactorsinpostmastectomyradiotherapypatients
AT wangq radiationinducedlymphopeniaprognosisandriskfactorsinpostmastectomyradiotherapypatients
AT gey radiationinducedlymphopeniaprognosisandriskfactorsinpostmastectomyradiotherapypatients
AT mux radiationinducedlymphopeniaprognosisandriskfactorsinpostmastectomyradiotherapypatients